NEW YORK (GenomeWeb) – DuPont and Caribou Biosciences today announced a strategic alliance focused on agricultural applications of CRISPR/Cas9 genome editing.

Under the terms of the agreement, DuPont and Caribou have cross-licensed their patent portfolios. DuPont will receive exclusive intellectual property rights for CRISPR/Cas9 technology for application in row crops and non-exclusive rights in other agricultural and industrial applications.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.